| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -71% |
| 3Y CAGR | +41% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -84% |
| 3Y CAGR | +24% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,795.40 +72.30 (2.66%) | 21,230.07 | 31.31 | 6.3 | ||
PfizerPFIZER | ₹4,095.40 -75.60 (1.81%) | 18,739.41 | 25.49 | 4.46 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,860.50 -16.00 (0.23%) | 17,146.63 | 101.09 | 19.65 | ||
Jubilant PharmovaJUBLPHARMA | ₹1,025.65 +6.65 (0.65%) | 16,339.40 | 46.5 | 2.3 |